Aurobindo Pharma Shares Tank 7% After USFDA Action

Aurobindo Pharma added it is confident that these OAI classifications will not have an impact on disruption of supplies or the revenue from operations of these facilities.

from Top Business News- News18.com http://bit.ly/2W0Rje3